AIP variant causing familial prolactinoma.

Abstract

Pathogenic variants in the aryl hydrocarbon receptor-interacting protein (AIP) gene are increasingly recognised as a cause of familial isolated pituitary adenoma. AIP-associated tumours are most commonly growth hormone (GH) producing. In our cohort of 175 AIP mutation positive patients representing 93 kindreds, 139 (79%) have GH excess, 19 have prolactinoma (17 familial and 2 sporadic cases) and out of the 17 clinically non-functioning tumours 4 were subsequently operated and found to be GH or GH & prolactin immunopositive adenoma. Here we report a family with an AIP variant, in which multiple family members are affected by prolactinoma, but none with GH excess. To our knowledge this is the first reported family with an AIP pathogenic variant to be affected solely by prolactinoma. These data suggest that prolactinoma families represent a small subset of AIP mutation positive kindreds, and similar to young-onset sporadic prolactinomas, AIP screening would be indicated.

• Authors: David M Carty, Rachael Harte, Russell S Drummond, Rebecca Ward, Kesson Magid, David Collier, Martina Owens, Márta Korbonits
• Journal: Pituitary (Pituitary) Vol. 24 Issue 1 Pg. 48-52 (Feb 2021) ISSN: 1573-7403 [Electronic] United States
• PMID: 33010004 (Publication Type: Case Reports, Journal Article)

Topics

• Adenoma (epidemiology, metabolism)
• Adult
• Female
• Genetic Testing
• Growth Hormone-Secreting Pituitary Adenoma (epidemiology, metabolism)
• Humans
• Male
• Middle Aged
• Mutation (genetics)
• Pedigree
• Pituitary Neoplasms (epidemiology, metabolism)
• Prolactinoma (epidemiology, metabolism)